How AI is Matching the Right Cancer Drug to the Right Patient w/ Ron Alfa Co-Founder & CEO of Noetik
Published July 7, 2026
Views 7.27K | Likes 425 | Comments 13
At a glance
Views
7,278
Likes
425
Comments
13
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
What if the reason ~95% of cancer drugs fail in the clinic isn't the drug at all — but the patient they were given to? In this episode of Catalio Conversations, Martha Petrocheilos sits with Ron Alfa, Co-Founder & CEO of Noetik, who reveals a radically contrarian thesis: the industry is great at making drugs, but has n…
- Published
- July 7, 2026
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.